Basit öğe kaydını göster

dc.contributor.authorKiremit, Murat Can
dc.contributor.authorErdoğan Çakır, Aslı
dc.contributor.authorArslan, Ferhat
dc.contributor.authorÖrmeci̇, Tuǧrul
dc.contributor.authorErkurt, Bülent
dc.contributor.authorAlbayrak, Selami
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:56:56Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:56:56Z
dc.date.issued2015en_US
dc.identifier.citationKiremit, M. C., Erdoğan Çakır, A., Arslan, F., Örmeci̇, T., Erkurt, B. ve Albayrak, S. (2015). The bladder carcinoma secondary to schistosoma mansoni infection: A case report with review of the literature. International Journal of Surgery Case Reports, 13, 76-78. https://dx.doi.org/10.1016/j.ijscr.2015.05.038en_US
dc.identifier.issn2210-2612
dc.identifier.urihttps://dx.doi.org/10.1016/j.ijscr.2015.05.038
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2857
dc.descriptionWOS: 000361072800022en_US
dc.descriptionPubMed ID: 26125519en_US
dc.description.abstractINTRODUCTION: Schistosomiasis is a rare condition in Turkey but remains second most prevelant parasitic infestation worldwide. PRESENTATION OF CASE: A 67-years old male patient admitted to a hospital with macroscopic hematuria. Bladder tumor was diagnosed and referred to our department for the treatment. Transurethral resection of bladder tumor was performed and pathological examination revealed high-grade papillary urothelial carcinoma and Schistosoma mansoni eggs. The patient used praziquantel 40mg orally for the treatment of Schistosomiasis and intravesical immunotherapy was applied 6 weeks along per week. Neither recurrence of tumor nor S. mansoni eggs in the urine were detected at the 18th month. DISCUSSION: In spite of well-known etiological relationships between Schistosoma haematobium and bladder cancer, there is very limited number of cases of bladder carcinoma secondary to S. mansoni infestation in the literature. All of the reported 5 cases were from the rural regions of Brazil. On the other hand, it was noticed that pathological examination had been reported in only one of these cases, and the diagnosis was leiomyoma. Therefore, to the best of our knowledge, there is no data in the literature regarding the clinical course of the transitional cell carcinoma secondary to S. mansoni. CONCLUSION: Regarding the increasing travels all around the world, clinicians should remember that Schistosoma infection is certainly a part of the differential diagnosis of bladder carcinoma, even if the patients are not from endemic regions.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectSchistosoma Mansonien_US
dc.subjectBladder Canceren_US
dc.subjectTrematodeen_US
dc.subjectInfestationen_US
dc.titleThe bladder carcinoma secondary to schistosoma mansoni infection: A case report with review of the literatureen_US
dc.typereviewen_US
dc.relation.ispartofInternational Journal of Surgery Case Reportsen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyoloji Ana Bilim Dalıen_US
dc.authorid0000-0003-0128-6947en_US
dc.authorid0000-0001-8945-2385en_US
dc.authorid0000-0002-4245-7506en_US
dc.identifier.volume13en_US
dc.identifier.startpage76en_US
dc.identifier.endpage78en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.1016/j.ijscr.2015.05.038en_US
dc.identifier.scopusqualityQ3en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess